Alzinova (ALZ)

Last close As at 08/12/2025

SEK1.71

−0.21 (−11.05%)

Market capitalisation

SEK201m

Alzinova is a Swedish biopharmaceutical company in clinical development specializing in the treatment of Alzheimer’s disease.

Latest Insights

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare

Key Management

  • Tord Labuda

    CEO

  • Erik Kullgren

    CFO